DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible. <See Attachment on the next page.> Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) The purpose of this modification is to provide an additional allotment of funds for continued performance of this contract. This modification also makes an administrative change to Clauses I.7 and I.11.
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) Modification Control Number: oconnels0768 See Attached Except as provided herein, all terms and conditions of the document referenced in item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) See Continuation Sheet Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect. 15A NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print) Xxxxxx X Xxxxxxx Xx 15B. CONTRACTOR/OFFEROR 15C. DATE SIGNED 16B. UNITED STATES OF AMERICA (Signature of Contracting Officer) 16C. DATE SIGNED 2019 JAN 24 (Signature of person authorized to sign) NSN 7540-01-152-8070 Previous edition unusable STANDARD FORM 30 (REV. 10-83) Prescribed by GSA FAR (48 CFR) 53.243 CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED: SPE8EC-18-D-0017 / P00001 PAGE 2 OF 2 PAGES The "Note" referenced on page 14 of the original solicitation (under the ADDENDUM TO FAR 52.212-4), which is incorporated by reference into the basic contract, is revised from: "FAR 52.246-2, Inspection of Supplies -Fixed Price (AUG 1996) is hereby included in this solicitation and resulting contract and takes precedence over FAR 52.212-4 (a)," to: "Inspection/Acceptance shall be in accordance with FAR 52.246-2, Inspection of Supplies -Fixed Price (AUG 1996) or FAR 52.212-4 Contract Terms and conditions -Commercial Items (JAN 2017) paragraph (al Inspection/Acceptance." The applicable clause will be determined by the Contracting Officer upon the issuance of each delivery order. In the absence of either clause, FAR 52.246-2, Inspection of Supplies -Fixed Price (AUG 1996) applies. CONTINUED ON NEXT PAGE MINUTEMAN INTERNATIONAL
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) The purpose of this modification is to make changes to the company's address, CAGE code, DUNS number, and assigned DCMA office of the subject contract. See page 2 for details. Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) Revise quantity of CLIN 0004 in P00004 dated November 3, 2004 from 1 test to 2 tests, and to increase the total value of CLIN 0004 to $104,648. The Statement of Work Paragr aph C.1.4.b. is revised to read: All testing “other than” Pentavalent Botulinum Vaccine.... as included on the attached SOW. FAR 52.216-19 and FAR 52.232-32 of the contract are not applicable to CLIN 0004. Funding will be provided on individual delivery orders. All other terms and conditions of the contract remain unchanged and in full force and effect. Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect. — 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print) 15A. NAME AND TITLE OF SIGNER (Type or print) LXXX X. XXXXXXXXX Rxxxxx Xxxxxx, President & CEO TEL: EMAIL: —— — 15B. CONTRACTOR/OFFEROR 16B. UNITED STATES OF AMERICA By /s/ Rxxxxx Xxxxxx BY_/s/ Lxxx X. Xxxxxxxxx___ —— 15C. DATE SIGNED —— 16C. DATE SIGNED (Signature of person authorized to sign) 11/12/04 (Signature of Contracting Officer) Nov 16, 2004 —— —— —— — STANDARD FORM 30 (REV. 10-83) EXCEPTION TO SF 30 Prescribed by GSA APPROVED BY OIRM 11-84 30-105-04 FAR (48 CFR) 53.243 NO SUPPLIES/SERVICES MAX QUANTITY UNIT UNIT PRICE MAX AMOUNT 0004 2 $ 52,324.00 $ 104,648.00 Pentavalent Botulinum Testing FFP Conduct Pentavalent Botulinum Long Term Interval Testing Testing for lots PBP003 and PBP0004 using Protocol Numbers LTIT2003-001 and LTIT2003-002.
DESCRIPTION OF AMENDMENT. Signature: Insert a reference to the item in the Agreement (name of document and name of clause) that changes and enter the change (enter new text).. For the Customer: For the Vendor: 1. 2. 3. 4.
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) Modification Control Number: (b) (6) The purpose of this modification is to change the “administered by” organization from S0514A to N68936 as show n herein. This modification also changes the “issued by” from (b) (6) and updates the points of contact in Section A. In addition, Clause 5252.242-9511 Contract Administration Data (NAVAIR)(SEP 2012) has been updated to change PCO and contract information from Xxxxx Xxxxxxxx to Xxxxx Xxxxxxx. Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect. 15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print) XXXXX X XXXXXXX XX / PROCURING CONTRACTING OFFICER TEL: (000) 000-0000 EMAIL: xxxxx.x.xxxxxxx.civ@xx.xxxx.xxx 15B. CONT RACT OR/OFFEROR (Signature of person authorized to sign) 15C. DATE SIGNED 16B. UNITED ST AT ES OF AMERICA BY (Signature of Contracting Officer) 16C. DATE SIGNED 16-Sep-2021 EXCEPTION TO SF 30 APPROVED BY OIRM 11-84 00-000-00 STANDARD FORM 30 (Rev. 10-83) Prescribed by GSA SECTION SF 30 BLOCK 14 CONTINUATION PAGE SUMMARY OF CHANGES
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section heading, including solicitation/contract, subject matter where feasible.) Purpose: To exercise an option for CLIN 0003A, CLIN 0003B, CLIN 0004, CLIN 0005, and the design portion of CLIN 0008; and embed contract milestones into this contract and modification; and add an advanced understanding under article B 8 as described on page 2. The funded amount is increased by $165,205,217 from $1,797,372, to $167,002,589. The total contract amount is increased by $165,205,217 from $1,797,372 to $167,002,589. The contract expiration date is extended from 9/22/06 to 9/22/09. Except as provided herein, all terms and conditions of the document referenced in item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
